Non-genomic inhibitory signaling of β-carotene in squamous cell carcinoma of the lungs

10Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Studies have suggested that retinoids prevent lung cancer by interacting with nuclear retinoid receptors. However, clinical trials with β-carotene increased lung cancer mortality. We recently showed that β-carotene stimulates the proliferation of small airway-derived adenocarcinoma by increasing cAMP signaling. Here, we have tested the hypothesis that β-carotene may stimulate squamous cell carcinoma cells via similar mechanisms. We determined the effects of β-carotene in cell lines from squamous cell carcinomas and large airway epithelia on proliferation by MTT assays in the presence and absence of inhibitors. Signaling via cAMP/PKA was measured by immunoassays and PKA activation assay. Phosphorylated ERK1/2 was determined by Western blotting. β-carotene significantly inhibited proliferation and phosphorylation of ERK1/2 by Gus-mediated signaling involving adenylyl cyclase, cAMP, PKA and ERK1/2. These findings introduce a non-genomic inhibitory mechanism of β-carotene and emphasize the need for the development of marker-guided lung cancer prevention.

Cite

CITATION STYLE

APA

Al-Wadei, H. A. N., & Schuller, H. M. (2009). Non-genomic inhibitory signaling of β-carotene in squamous cell carcinoma of the lungs. International Journal of Oncology, 34(4), 1093–1098. https://doi.org/10.3892/ijo_00000236

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free